Coherus BioSciences Inc (CHRS)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 45.42M | 45.35M | 32.44M | 58.72M | 74.57M | 91.52M | 77.06M | 64.98M |
営業利益 | -80.45M | -51.49M | -67.75M | -34.54M | -32.01M | -68.91M | -49.73M | -20.51M |
税引前収入 | -86.65M | -58.87M | -75.73M | -42.87M | -40.02M | -79.65M | 102.88M | -12.92M |
純利益 | -86.65M | -58.87M | -75.73M | -42.87M | -39.64M | -79.65M | 102.88M | -12.92M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -79.11M | -51.39M | -66.14M | -32.8M | -29.75M | -71.83M | 113.99M | 158.69M |
EBITDA | -79.45M | -50.44M | -66.8M | -35.49M | -29.28M | -67.84M | -48.22M | -19.32M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 190.11M | 1.56M | 0 | 356.07M | 475.82M | 326.55M | 211.04M | 257.24M |
営業利益 | -115.93M | -232.14M | -204.42M | 107.77M | 156.32M | -263.86M | -256.88M | -203.2M |
税引前収入 | -127.79M | -238.29M | -209.41M | 92.78M | 135.71M | -287.1M | -291.75M | -238.27M |
純利益 | -127.34M | -238.17M | -209.34M | 89.83M | 132.24M | -287.1M | -291.75M | -237.89M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.78 | -3.98 | -3.065 | 1.277 | 1.824 | -3.732 | -3.7 | -2.136 |
EBIT | -119.76M | -228.68M | -200.55M | 108.54M | 156.61M | -264.14M | -254.96M | -200.53M |
EBITDA | -112.94M | -228.74M | -197.32M | 111.14M | 159.21M | -260.4M | -253.18M | -199.41M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約